Pradaxa Lawsuit Multi District Litigation. Contact (800) 611-7080 for Pradaxa Lawsuit information. It has been reported that a motion was filed before a Judicial Panel on Multidistrict Litigation (MDL) to consolidate the existing Pradaxa Lawsuit cases as well as future Pradaxa Lawsuit cases into Federal Court in the Southern District of Illinois. The panel’s ruling on the motion has yet to occur or be reported.
A Multi District litigation is often confused with a Class Action Lawsuit. In a Pradaxa Lawsuit Multi District Litigation all or the majority of the current and future Pradaxa Lawsuits would be heard in one court under a single Judge however, each individual Pradaxa Lawsuit plaintiffs case would remain a separate lawsuit that could be individually settled or tried on the merits and specifics of the individual case. In a Pradaxa Class Action Lawsuit, all cases would be essentially heard as one case. For a Pradaxa Class Action Lawsuit to occur the injuries suffered by all of the plaintiffs would need to be similar enough to form a “class” in which the facts of one plaintiffs case are considered to be identical or near identical to all other plaintiffs in the class. Pharmaceutical Lawsuits rarely become Class Action Lawsuits as it would be very uncommon for a large group of Plaintiffs to sustain injuries and damages that were similar enough for them to be considered a “class”.
The current lawsuits that have been filed as a result of injuries related to Pradaxa center around evidence that there is a link between taking Pradaxa and suffering severe bleeding injuries. Bleeding injuries can be internal or external. Internal bleeding injuries can occur most anywhere in the body including the brain as well as in other organs that can lead to death or permanent disability.
If you or a family member took Pradaxa and sustained a bleeding related injury and would like more information or if you would like to arrange a free consultation with an attorney taking clients for the Pradaxa Lawsuit, please contact us today.